Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:45 AM
Ignite Modification Date:
2025-12-25 @ 12:45 AM
NCT ID:
NCT06165367
Eligibility Criteria:
Inclusion Criteria:
* All frozen embryo transfer (FET) cycles with euploid blastocysts biopsied and vitrified on Day 5 after PGT-A.
* Rank of randomization based on embryo quality.
* Only hormonal replacement theraphy (HRT) cycle regimen.
* Women aged 18 years to 46 years.
* Having at least 1 chromosomally normal vitrified blastocyst(s) on Day 5 available for transfer.
* All sperm samples.
* BMI between 18 and 35.
Exclusion Criteria:
* FET cycles with preimplantation genetic testing for monogenic disorders (PGT-M) and for structural rearrangements (PGT-SR).
* FET cycles with mosaic / aneuploid blastocysts.
* FET cycles with unknown outcome.
* FET cycles with Day 6 or Day 7 biopsied blastocysts.
* FET with patients' endometrium preparation with treatments other than HRT.
* FET where PGT-A was performed for gender selection.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
46 Years
Study:
NCT06165367
Study Brief:
Protocol Section:
NCT06165367